pop quiz

COVID-19 Vaccines for Patients Who Are Immunocompromised

© 2023 HMP Global. All Rights Reserved.
Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of Consultant360 or HMP Global, their employees, and affiliates.

Research Summaries

Research Summary

Research Summary

Quantum Molecular Resonance May Relieve Symptoms of Dry Eye Disease

11/14/2024

Miranda Manier, BA

In a randomized trial, high-frequency electrotherapy improved symptoms and some clinical signs of dry eye disease, offering a potential new treatment for this common condition.

11/14/2024

Research Summary

older person talking to doctor on computer

Research Summary

Do Telehealth Mindfulness Interventions Improve Pain Management for Veterans?

11/12/2024

Miranda Manier, BA

A recent clinical trial demonstrates that both group and self-paced telehealth mindfulness-based interventions can potentially enhance pain-related function and biopsychosocial outcomes in veterans with...

11/12/2024

Research Summary

Research Summary

Neurofilament Light Chain as an Indicator of Neurological Damage in Acute Hepatic Porphyria

11/08/2024

Miranda Manier, BA

New research reveals that elevated serum neurofilament light chain levels correlate with both acute and chronic neurological damage in acute hepatic porphyria, offering clinicians a potential tool for...

11/08/2024

Research Summary

Can Acupuncture Ease Pain and Improve Mood for Patients With Dry Eye Disease?

11/08/2024

Miranda Manier, BA

In a pilot study, acupuncture reduced ocular pain and inflammation while improving mental well-being and tear stability in patients with dry eye disease.

11/08/2024

Depression Care360

Esketamine Nasal Spray Efficacious in TRD Vs. Placebo

11/06/2024

Esketamine (ESK) nasal spray monotherapy was found to be efficacious over placebo in adults with treatment-resistant depression, according to recent randomized, double-blind study results reported in a...

11/06/2024

COVID-19 Vaccines for Patients Who Are Immunocompromised

© 2023 HMP Global. All Rights Reserved.Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of Consultant360 or HMP Global, their employees, and affiliates.

© 2023 HMP Global. All Rights Reserved.
Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of Consultant360 or HMP Global, their employees, and affiliates.